Prenatal screens blood type AB positive, antibody negative, rubella immune, RPR nonreactive, hepatitis B surface antigen negative, group beta strep status unknown.
The pregnancy was complicated by vaginal bleeding and cervical diltation prompting admission to the [**Hospital6 256**] on [**2133-4-19**], for treatment with betamethasone and magnesium sulfate.
The mother continued to have episodic vaginal bleeding and contractions which prompted delivery by cesarean section on [**2133-4-26**].
The infant emerged with spontaneous respirations, did require brief positive pressure ventilation, was intubated for respiratory distress in the delivery room.
She was admitted to the neonatal intensive care unit for treatment of prematurity.
ANTHROPOMETRIC MEASURES AT BIRTH:  Weight 760 g, 25-50th percentile.
She remained on that through     day of life 58 when she transitioned to nasal cannula O2.
She has required treatment for     apnea of prematurity with caffeine and this was     discontinued on [**7-16**].
She received 1 course of treatment with     indomethacin.
Fluids, electrolytes and nutrition: [**Known lastname 12466**] was initially     NPO and maintained on intravenous fluids.
She had an     umbilical venous catheter placed at birth.
She is     currently on adlib feeds of MM28 with Neosure Powder.
Infectious disease: Due to her prematurity and the     unknown group B strep status of her mother, [**Name (NI) 12466**] was     evaluated for sepsis upon admission to the neonatal     intensive care unit.
A white blood cell count and     differential were within normal limits and a blood     culture obtained prior to starting intravenous ampicillin     and gentamicin was no growth at 48 hours.
She received a 1-week course of vancomycin     and gentamicin for presumed sepsis, from day of life 14-     21.
All cultures including cerebral spinal fluid were     negative.
She is being treated with supplemental iron.
Gastrointestinal: [**Known lastname 12466**] required treatment for     unconjugated hyperbilirubinemia with phototherapy.
CARE RECOMMENDATIONS:       Iron and vitamin D supplementation: Iron supplementation     is recommended for preterm and low birth weight infants     until 12 months corrected age.
All infants that     predominantly breast milk should receive vitamin D     supplementation at 200 IU (may be provided as a     multivitamin preparation) daily until 12 months corrected     age.
Immunizations: Hepatitis B vaccine was administered on     [**2133-5-30**].
Pediarix was administered on [**2133-7-3**].
Haemophilus influenza B vaccine on [**2133-7-5**],     pneumococcal 7-valent conjugant vaccine on [**2133-7-4**].
Immunizations recommended: Synagis RSV prophylaxis should     be considered from [**Month (only) **] through [**Month (only) 958**] for infants who     meet any of the following 4 criteria: 1) born at less     than 32 weeks, 2) born between 32 and 35 weeks with 2 of     the following: Day care during RSV season, a smoker in     the household, neuromuscular disease, airway     abnormalities, or school-age siblings, 3) with chronic     lung disease, or 4) hemodynamically significant     congenital heart disease.
Respiratory distress syndrome status post treatment with     surfactant.
Patent ductus arteriosus status post treatment with     indomethacin.
